The death rate from prostate cancer is expected to drop by almost 10% in the UK this year, as better diagnoses and treatments are contributing to a reduction in almost all countries of the European Union.
Prostate cancer is the most common cancer in men, with about one in eight men in the UK who contract the disease in their lifetime, which equates to around 48,000 men diagnosed each year.
However, researchers from the University of Milan have found a marked improvement in survival rates in the UK and the EU, with doctors adopting up-to-date surgical and radiotherapy techniques as well as a new form of therapy. deprivation of androgens, a common practice. hormone treatment for prostate cancer.
The researchers calculated that there will be